Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors
- PMID: 31111878
- DOI: 10.1093/annonc/mdz120
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors
Abstract
In the past decades, new cancer treatment approaches for children and adolescents have led to a decrease in recurrence rates and an increase in long-term survival. Recent studies have focused on the evaluation of the late effects on bone of pediatric cancer-related treatments, such as chemotherapy, radiation and surgery. Treatment of childhood cancer can impair the attainment of peak bone mass, predisposing to premature onset of low bone mineral density, or causing other bone side-effects, such as bone quality impairment or avascular necrosis of bone. Lower bone mineral density and microarchitectural deterioration can persist during adulthood, thereby increasing fracture risk. Overall, long-term follow-up of childhood cancer survivors is essential to define specific groups at higher risk of long-term bone complications, identify unrecognized long-term adverse effects, and improve patient care. Children and adolescents with a cancer history should be carefully monitored, and patients should be informed of possible late complications of their previous medical treatment. The International Osteoporosis Foundation convened a working group to review the bone complications of pediatric cancer survivors, outlining recommendations for the management of bone health, in order to prevent and treat these complications.
Keywords: chemotherapy; childhood cancer; childhood cancer survivor; osteonecrosis; osteoporosis; radiotherapy.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.Pediatrics. 2008 Mar;121(3):e705-13. doi: 10.1542/peds.2007-1396. Pediatrics. 2008. PMID: 18310191 Review.
-
Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Lancet Diabetes Endocrinol. 2021 Sep;9(9):622-637. doi: 10.1016/S2213-8587(21)00173-X. Epub 2021 Jul 30. Lancet Diabetes Endocrinol. 2021. PMID: 34339631 Free PMC article. Review.
-
Osteoporosis in children and adolescents: diagnosis, risk factors, and prevention.J Pediatr Endocrinol Metab. 2001 Jul-Aug;14(7):833-59. doi: 10.1515/jpem.2001.14.7.833. J Pediatr Endocrinol Metab. 2001. PMID: 11515725 Review.
-
Italian cancer figures, report 2012: Cancer in children and adolescents.Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. Epidemiol Prev. 2013. PMID: 23585445 English, Italian.
-
Bone mineral density deficits and fractures in survivors of childhood cancer.Curr Osteoporos Rep. 2013 Dec;11(4):329-37. doi: 10.1007/s11914-013-0165-0. Curr Osteoporos Rep. 2013. PMID: 24043370 Free PMC article. Review.
Cited by
-
Dose-Related Effect of Chemotherapy on Bone Mineral Density Among Pediatric Acute Lymphoblastic Leukemia Survivors.J Pediatr Pharmacol Ther. 2024;29(1):53-60. doi: 10.5863/1551-6776-29.1.53. Epub 2024 Feb 7. J Pediatr Pharmacol Ther. 2024. PMID: 38332966 Free PMC article.
-
Determinants of bone parameters in young paediatric cancer survivors: the iBoneFIT project.Pediatr Res. 2023 Oct;94(4):1538-1546. doi: 10.1038/s41390-023-02645-8. Epub 2023 May 18. Pediatr Res. 2023. PMID: 37202528
-
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth.Sci Rep. 2023 May 17;13(1):8054. doi: 10.1038/s41598-023-34965-4. Sci Rep. 2023. PMID: 37198212 Free PMC article.
-
Effect of exercise on bone health in children and adolescents with cancer during and after oncological treatment: A systematic review and meta-analysis.Front Physiol. 2023 Mar 14;14:1088740. doi: 10.3389/fphys.2023.1088740. eCollection 2023. Front Physiol. 2023. PMID: 37035662 Free PMC article.
-
Transition of young adults with metabolic bone diseases to adult care.Front Endocrinol (Lausanne). 2023 Mar 17;14:1137976. doi: 10.3389/fendo.2023.1137976. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37008909 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
